5.46 - 5.56
4.95 - 8.28
1.3K / 2.4K (Avg.)
-277.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.11%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-61.24%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-37.55%
Negative EBIT growth while STERV.HE is at 65.82%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-37.55%
Negative operating income growth while STERV.HE is at 65.82%. Joel Greenblatt would press for urgent turnaround measures.
-1.12%
Negative net income growth while STERV.HE stands at 241.94%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-1.12%
Negative EPS growth while STERV.HE is at 231.25%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-1.12%
Negative diluted EPS growth while STERV.HE is at 253.33%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-28.76%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-3.72%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-27.90%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-32.57%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-16.60%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
51.94%
10Y OCF/share CAGR under 50% of STERV.HE's 278.39%. Michael Burry would worry about a persistent underperformance in cash creation.
455.18%
5Y OCF/share CAGR above 1.5x STERV.HE's 72.04%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
292.15%
Positive 3Y OCF/share CAGR while STERV.HE is negative. John Neff might see a big short-term edge in operational efficiency.
136.84%
Net income/share CAGR at 50-75% of STERV.HE's 273.17%. Martin Whitman might question if the firm’s product or cost base lags behind.
216.86%
5Y net income/share CAGR above 1.5x STERV.HE's 35.81%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-39.15%
Negative 3Y CAGR while STERV.HE is 61.96%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
6.18%
Positive growth while STERV.HE is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
0.42%
Positive 5Y equity/share CAGR while STERV.HE is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
9.72%
Positive short-term equity growth while STERV.HE is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-30.12%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-5.02%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-0.63%
Negative asset growth while STERV.HE invests at 3.01%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.28%
Under 50% of STERV.HE's 8.15%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-2.10%
We’re deleveraging while STERV.HE stands at 1.05%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
8.02%
We expand SG&A while STERV.HE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.